Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Challenges in the management of the transgender patient with sickle cell disease.

Ronda J, Nord A, Arrington-Sanders R, Naik R, Takemoto CM, Baskin J, Lanzkron S, Pecker LH.

Am J Hematol. 2018 Nov;93(11):E360-E362. doi: 10.1002/ajh.25242. Epub 2018 Oct 12. No abstract available.

PMID:
30094866
2.

Diagnosis of congenital and acquired focal lesions in the neck, abdomen, and pelvis with contrast-enhanced ultrasound: a pictorial essay.

Thimm MA, Rhee D, Takemoto CM, Karnsakul W, Cuffari C, Guerrerio AL, Garcia A, Gearhart J, Huisman TAGM, Hwang M.

Eur J Pediatr. 2018 Oct;177(10):1459-1470. doi: 10.1007/s00431-018-3197-8. Epub 2018 Jul 3.

PMID:
29971555
3.

Association of Perioperative Red Blood Cell Transfusions With Venous Thromboembolism in a North American Registry.

Goel R, Patel EU, Cushing MM, Frank SM, Ness PM, Takemoto CM, Vasovic LV, Sheth S, Nellis ME, Shaz B, Tobian AAR.

JAMA Surg. 2018 Sep 1;153(9):826-833. doi: 10.1001/jamasurg.2018.1565.

PMID:
29898202
4.

A novel diagnostic algorithm for heparin-induced thrombocytopenia.

Zheng G, Streiff MB, Allison D, Takemoto CM, Salimian K, Morris P, Jani J, McCord R, Kickler TS.

Int J Lab Hematol. 2018 May 13. doi: 10.1111/ijlh.12853. [Epub ahead of print]

PMID:
29756276
5.

Approach to pancytopenia: Diagnostic algorithm for clinical hematologists.

Gnanaraj J, Parnes A, Francis CW, Go RS, Takemoto CM, Hashmi SK.

Blood Rev. 2018 Sep;32(5):361-367. doi: 10.1016/j.blre.2018.03.001. Epub 2018 Mar 5. Review.

PMID:
29555368
6.

Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathway.

Palam LR, Mali RS, Ramdas B, Srivatsan SN, Visconte V, Tiu RV, Vanhaesebroeck B, Roers A, Gerbaulet A, Xu M, Janga SC, Takemoto CM, Paczesny S, Kapur R.

JCI Insight. 2018 Feb 22;3(4). pii: 94679. doi: 10.1172/jci.insight.94679. [Epub ahead of print]

7.

Diagnostic utility of telomere length testing in a hospital-based setting.

Alder JK, Hanumanthu VS, Strong MA, DeZern AE, Stanley SE, Takemoto CM, Danilova L, Applegate CD, Bolton SG, Mohr DW, Brodsky RA, Casella JF, Greider CW, Jackson JB, Armanios M.

Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):E2358-E2365. doi: 10.1073/pnas.1720427115. Epub 2018 Feb 20. Erratum in: Proc Natl Acad Sci U S A. 2018 Apr 23;:.

8.

Pediatric Hospital Acquired Venous Thromboembolism.

Witmer CM, Takemoto CM.

Front Pediatr. 2017 Sep 19;5:198. doi: 10.3389/fped.2017.00198. eCollection 2017. Review.

9.

The Clinical Utility of the Heparin Neutralization Assay in the Diagnosis of Heparin-Induced Thrombocytopenia.

Zheng G, Streiff MB, Takemoto CM, Bynum J, Gelwan E, Jani J, Judge D, Kickler TS.

Clin Appl Thromb Hemost. 2018 Jul;24(5):749-754. doi: 10.1177/1076029617721013. Epub 2017 Aug 4.

PMID:
28774196
10.

Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.

Yang W, Xu R, Porras JL, Takemoto CM, Khalid S, Garzon-Muvdi T, Caplan JM, Colby GP, Coon AL, Tamargo RJ, Huang J, Ahn ES.

J Neurosurg Pediatr. 2017 Sep;20(3):232-238. doi: 10.3171/2017.1.PEDS16576. Epub 2017 Jul 7.

PMID:
28686127
11.

First report on the safety and efficacy of an extended half-life glycoPEGylated recombinant FVIII for major surgery in severe haemophilia A.

Hampton K, Chowdary P, Dunkley S, Ehrenforth S, Jacobsen L, Neff A, Santagostino E, Sathar J, Takedani H, Takemoto CM, Négrier C.

Haemophilia. 2017 Sep;23(5):689-696. doi: 10.1111/hae.13246. Epub 2017 May 4.

PMID:
28470862
12.

High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia.

Gamper CJ, Takemoto CM, Chen AR, Symons HJ, Loeb DM, Casella JF, Dezern AE, King KE, McGonigle AM, Jones RJ, Brodsky RA.

J Pediatr Hematol Oncol. 2016 Nov;38(8):627-635.

13.

Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012.

Goel R, King KE, Takemoto CM, Ness PM, Tobian AA.

Transfusion. 2016 Jun;56(6):1451-8. doi: 10.1111/trf.13586. Epub 2016 Apr 15.

14.

Risk Factors for Venous Thromboembolism in Pediatric Trauma Patients and Validation of a Novel Scoring System: The Risk of Clots in Kids With Trauma Score.

Yen J, Van Arendonk KJ, Streiff MB, McNamara L, Stewart FD, Conner KG, Thompson RE, Haut ER, Takemoto CM.

Pediatr Crit Care Med. 2016 May;17(5):391-9. doi: 10.1097/PCC.0000000000000699.

15.

Corrigendum: The genomic landscape of juvenile myelomonocytic leukemia.

Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T, Esquivel E, Yu A, Seepo S, Olsen SR, Rosenberg M, Archambeault SL, Abusin G, Beckman K, Brown PA, Briones M, Carcamo B, Cooper T, Dahl GV, Emanuel PD, Fluchel MN, Goyal RK, Hayashi RJ, Hitzler J, Hugge C, Liu YL, Messinger YH, Mahoney DH Jr, Monteleone P, Nemecek ER, Roehrs PA, Schore RJ, Stine KC, Takemoto CM, Toretsky JA, Costello JF, Olshen AB, Stewart C, Li Y, Ma J, Gerbing RB, Alonzo TA, Getz G, Gruber TA, Golub TR, Stegmaier K, Loh ML.

Nat Genet. 2016 Jan;48(1):101. doi: 10.1038/ng0116-101a. No abstract available.

PMID:
26711114
16.

Improving evidence on anticoagulant therapies for venous thromboembolism in children: key challenges and opportunities.

Goldenberg NA, Takemoto CM, Yee DL, Kittelson JM, Massicotte MP.

Blood. 2015 Dec 10;126(24):2541-7. doi: 10.1182/blood-2015-06-651539. Epub 2015 Oct 23.

17.

The genomic landscape of juvenile myelomonocytic leukemia.

Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T, Esquivel E, Yu A, Seepo S, Olsen S, Rosenberg M, Archambeault SL, Abusin G, Beckman K, Brown PA, Briones M, Carcamo B, Cooper T, Dahl GV, Emanuel PD, Fluchel MN, Goyal RK, Hayashi RJ, Hitzler J, Hugge C, Liu YL, Messinger YH, Mahoney DH Jr, Monteleone P, Nemecek ER, Roehrs PA, Schore RJ, Stine KC, Takemoto CM, Toretsky JA, Costello JF, Olshen AB, Stewart C, Li Y, Ma J, Gerbing RB, Alonzo TA, Getz G, Gruber T, Golub T, Stegmaier K, Loh ML.

Nat Genet. 2015 Nov;47(11):1326-1333. doi: 10.1038/ng.3400. Epub 2015 Oct 12. Erratum in: Nat Genet. 2015 Nov;47(11):1333. Nat Genet. 2016 Jan;48(1):101.

18.

Development of a new risk score for hospital-associated venous thromboembolism in critically-ill children not undergoing cardiothoracic surgery.

Arlikar SJ, Atchison CM, Amankwah EK, Ayala IA, Barrett LA, Branchford BR, Streiff MB, Takemoto CM, Goldenberg NA.

Thromb Res. 2015 Oct;136(4):717-22. doi: 10.1016/j.thromres.2015.04.036. Epub 2015 May 3.

PMID:
25979250
19.

Retrospective cohort study comparing activated partial thromboplastin time versus anti-factor Xa activity nomograms for therapeutic unfractionated heparin monitoring in pediatrics.

Trucco M, Lehmann CU, Mollenkopf N, Streiff MB, Takemoto CM.

J Thromb Haemost. 2015 May;13(5):788-94. doi: 10.1111/jth.12890. Epub 2015 Apr 13.

20.

Iron status is associated with asthma and lung function in US women.

Brigham EP, McCormack MC, Takemoto CM, Matsui EC.

PLoS One. 2015 Feb 17;10(2):e0117545. doi: 10.1371/journal.pone.0117545. eCollection 2015.

21.

Immune thrombocytopenia due to Trimethoprim-Sulfamethoxazole; under-recognized adverse drug reaction in children?

Hayashi M, Strouse JJ, Veltri MA, Curtis BR, Takemoto CM.

Pediatr Blood Cancer. 2015 May;62(5):922-3. doi: 10.1002/pbc.25430. Epub 2015 Feb 12. No abstract available.

22.

Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality.

Goel R, Ness PM, Takemoto CM, Krishnamurti L, King KE, Tobian AA.

Blood. 2015 Feb 26;125(9):1470-6. doi: 10.1182/blood-2014-10-605493. Epub 2015 Jan 14.

23.

Global microRNA expression is essential for murine mast cell development in vivo.

Oh SY, Brandal S, Kapur R, Zhu Z, Takemoto CM.

Exp Hematol. 2014 Oct;42(10):919-23.e1. doi: 10.1016/j.exphem.2014.07.266. Epub 2014 Sep 6.

24.

Hospital-associated venous thromboembolism in children: incidence and clinical characteristics.

Takemoto CM, Sohi S, Desai K, Bharaj R, Khanna A, McFarland S, Klaus S, Irshad A, Goldenberg NA, Strouse JJ, Streiff MB.

J Pediatr. 2014 Feb;164(2):332-8. doi: 10.1016/j.jpeds.2013.10.025. Epub 2013 Dec 12.

PMID:
24332452
25.

Computerized physician order entry improves compliance with a manual exchange transfusion protocol in the pediatric intensive care unit.

McCrory MC, Strouse JJ, Takemoto CM, Easley RB.

J Pediatr Hematol Oncol. 2014 Mar;36(2):143-7. doi: 10.1097/MPH.0b013e31828e55e6.

PMID:
23619120
26.

Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance.

Takemoto CM, Streiff MB, Shermock KM, Kraus PS, Chen J, Jani J, Kickler T.

Am J Clin Pathol. 2013 Apr;139(4):450-6. doi: 10.1309/AJCPS6OW6DYNOGNH.

PMID:
23525615
27.

Safety and efficacy of catheter directed thrombolysis in children with deep venous thrombosis.

Darbari DS, Desai D, Arnaldez F, Desai K, Kallen J, Strouse J, Streiff MB, Hong K, Takemoto CM.

Br J Haematol. 2012 Nov;159(3):376-8. doi: 10.1111/bjh.12025. Epub 2012 Aug 31. No abstract available.

PMID:
22934795
28.

Female factor IX deficiency due to maternally inherited X-inactivation.

Esquilin JM, Takemoto CM, Green NS.

Clin Genet. 2012 Dec;82(6):583-6. doi: 10.1111/j.1399-0004.2012.01842.x. Epub 2012 Jan 30.

PMID:
22233509
29.

Heparin-induced thrombocytopenia screening and management in pediatric patients.

Takemoto CM, Streiff MB.

Hematology Am Soc Hematol Educ Program. 2011;2011:162-9. doi: 10.1182/asheducation-2011.1.162. Review.

PMID:
22160029
30.

Venous thromboembolism in cystic fibrosis.

Takemoto CM.

Pediatr Pulmonol. 2012 Feb;47(2):105-12. doi: 10.1002/ppul.21566. Epub 2011 Oct 17. Review.

PMID:
22006666
31.

KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation.

Lee YN, Brandal S, Noel P, Wentzel E, Mendell JT, McDevitt MA, Kapur R, Carter M, Metcalfe DD, Takemoto CM.

Blood. 2011 Mar 31;117(13):3629-40. doi: 10.1182/blood-2010-07-293548. Epub 2011 Jan 27.

32.

Noonan syndrome: clinical features, diagnosis, and management guidelines.

Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall B, Pierpont ME, Roberts AE, Robinson W, Takemoto CM, Noonan JA.

Pediatrics. 2010 Oct;126(4):746-59. doi: 10.1542/peds.2009-3207. Epub 2010 Sep 27. Review.

PMID:
20876176
33.

Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis.

McDermott DH, De Ravin SS, Jun HS, Liu Q, Priel DA, Noel P, Takemoto CM, Ojode T, Paul SM, Dunsmore KP, Hilligoss D, Marquesen M, Ulrick J, Kuhns DB, Chou JY, Malech HL, Murphy PM.

Blood. 2010 Oct 14;116(15):2793-802. doi: 10.1182/blood-2010-01-265942. Epub 2010 Jul 8.

34.

PU.1 positively regulates GATA-1 expression in mast cells.

Takemoto CM, Brandal S, Jegga AG, Lee YN, Shahlaee A, Ying Y, Dekoter R, McDevitt MA.

J Immunol. 2010 Apr 15;184(8):4349-61. doi: 10.4049/jimmunol.0900927. Epub 2010 Mar 19.

35.

SHP-1 deficient mast cells are hyperresponsive to stimulation and critical in initiating allergic inflammation in the lung.

Zhang L, Oh SY, Wu X, Oh MH, Wu F, Schroeder JT, Takemoto CM, Zheng T, Zhu Z.

J Immunol. 2010 Feb 1;184(3):1180-90. doi: 10.4049/jimmunol.0901972. Epub 2009 Dec 30.

36.

D-dimer for the diagnosis of venous thromboembolism in children.

Strouse JJ, Tamma P, Kickler TS, Takemoto CM.

Am J Hematol. 2009 Jan;84(1):62-3. doi: 10.1002/ajh.21311. No abstract available.

37.

Rituximab for ITP: a long-term fix?

Takemoto CM.

Pediatr Blood Cancer. 2009 Feb;52(2):155-6. doi: 10.1002/pbc.21803. No abstract available.

PMID:
18985744
38.

Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia.

Farrar JE, Nater M, Caywood E, McDevitt MA, Kowalski J, Takemoto CM, Talbot CC Jr, Meltzer P, Esposito D, Beggs AH, Schneider HE, Grabowska A, Ball SE, Niewiadomska E, Sieff CA, Vlachos A, Atsidaftos E, Ellis SR, Lipton JM, Gazda HT, Arceci RJ.

Blood. 2008 Sep 1;112(5):1582-92. doi: 10.1182/blood-2008-02-140012. Epub 2008 Jun 5.

39.

Mast cell transcriptional networks.

Takemoto CM, Lee YN, Jegga AG, Zablocki D, Brandal S, Shahlaee A, Huang S, Ye Y, Gowrisankar S, Huynh J, McDevitt MA.

Blood Cells Mol Dis. 2008 Jul-Aug;41(1):82-90. doi: 10.1016/j.bcmd.2008.02.005. Epub 2008 Apr 14. Review.

40.

Lymphadenopathy as the primary manifestation of malignant transformation in two patients with severe congenital neutropenia.

Gamper CJ, Takemoto CM, Schowinsky J, Borowitz MJ, Horwitz MS, Strouse JJ.

Pediatr Blood Cancer. 2008 May;50(5):1072-5. doi: 10.1002/pbc.21485.

PMID:
18213714
41.

Catheter-directed thrombolysis of inferior vena cava thrombosis in a 13-day-old neonate and review of literature.

Khan JU, Takemoto CM, Casella JF, Streiff MB, Nwankwo IJ, Kim HS.

Cardiovasc Intervent Radiol. 2008 Jul;31 Suppl 2:S153-60. Epub 2007 Nov 15. Review.

PMID:
18004620
42.

Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease.

Strouse JJ, Takemoto CM, Keefer JR, Kato GJ, Casella JF.

Pediatr Blood Cancer. 2008 May;50(5):1006-12.

43.

Distinct and shared transcriptomes are regulated by microphthalmia-associated transcription factor isoforms in mast cells.

Shahlaee AH, Brandal S, Lee YN, Jie C, Takemoto CM.

J Immunol. 2007 Jan 1;178(1):378-88.

44.

Acquired coagulation factor inhibitors in children after topical bovine thrombin exposure.

Savage WJ, Kickler TS, Takemoto CM.

Pediatr Blood Cancer. 2007 Dec;49(7):1025-9.

PMID:
16526049
45.

The identification and functional characterization of a novel mast cell isoform of the microphthalmia-associated transcription factor.

Takemoto CM, Yoon YJ, Fisher DE.

J Biol Chem. 2002 Aug 16;277(33):30244-52. Epub 2002 May 30.

46.

Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice.

Weilbaecher KN, Motyckova G, Huber WE, Takemoto CM, Hemesath TJ, Xu Y, Hershey CL, Dowland NR, Wells AG, Fisher DE.

Mol Cell. 2001 Oct;8(4):749-58.

47.

c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi.

Wu M, Hemesath TJ, Takemoto CM, Horstmann MA, Wells AG, Price ER, Fisher DZ, Fisher DE.

Genes Dev. 2000 Feb 1;14(3):301-12.

48.

alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome.

Price ER, Horstmann MA, Wells AG, Weilbaecher KN, Takemoto CM, Landis MW, Fisher DE.

J Biol Chem. 1998 Dec 4;273(49):33042-7.

49.

Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3.

Weilbaecher KN, Hershey CL, Takemoto CM, Horstmann MA, Hemesath TJ, Tashjian AH, Fisher DE.

J Exp Med. 1998 Mar 2;187(5):775-85.

Supplemental Content

Loading ...
Support Center